KKR to Acquire 70% Stake in Kerala's Baby Memorial Hospital for Rs 2,000 Crore

Global private equity firm KKR has announced its acquisition of a controlling stake in Baby Memorial Hospital (BMH), based in Kerala. The US-headquartered company will acquire a 70% stake in the hospital chain for approximately Rs 2,000 crore. The definitive agreements have been signed, and the funds managed by KKR will facilitate this acquisition.

Representative image

Expansion Plans and Services

Founded by KG Alexander in 1987, BMH has grown into a prominent multi-speciality hospital chain in Kerala. It currently operates with a capacity of 1,000 beds across its hospitals in Calicut and Kannur. The hospital chain offers services in 40 medical and surgical departments, including cardiology, oncology, neurology, gastroenterology, paediatric, and orthopaedic care.

KKR's investment aims to support BMH's efforts to meet the increasing demand for quality healthcare services in India. The plan includes expanding the hospital network through both organic and inorganic growth strategies. This expansion may involve acquiring other healthcare facilities across the region.

KKR's Commitment to Healthcare

Akshay Tanna, KKR's head of private equity for India, emphasised the firm's focus on the healthcare sector. "We look forward to drawing from KKR's network and deep healthcare expertise to take BMH to its next phase of growth and deliver greater impact to its communities," Tanna stated. This investment is expected to help BMH expand its network of hospitals significantly.

KG Alexander, founder and chairman of BMH, expressed satisfaction with the partnership. He noted that leveraging global and local experience in the healthcare sector would enable BMH to accelerate growth and expand services across India. The investment will be made from KKR's Asian Fund IV.

KKR's Investment History

KKR has a history of investing in India's healthcare sector. Previous investments include Max Healthcare, J B Pharma (a branded formulations pharmaceutical company), and Gland Pharma (a pure-play generic injectable pharmaceutical products company). Since 2006, KKR has invested over USD 12 billion across 38 investments in India.

The acquisition of BMH aligns with KKR's strategy to enhance healthcare services in India. By supporting BMH's expansion plans, KKR aims to create a leading pan-India network of hospitals that provide accessible and high-quality healthcare services.

This strategic move by KKR is expected to bring significant improvements to India's healthcare infrastructure. The partnership will likely benefit communities by providing better access to advanced medical care and facilities.